It was reported that cleo® 90 infusion sets began to have a reaction with inflammation at infusion sites, becoming more inflamed and infected with pus.Blood glucose was adversely affected and was reported to be at 484mg/dl.Small ketone levels were reported.Separate injections were conducted to address the high blood glucose.Customer was given oral and topical antibiotics from a healthcare professional to address the infusion site infections.The customer noted they cleaned and dried site prior to infusion set application, sets were not left in greater than 3 days, and there had not been a change in medications or diet.See mfr: 2183502-2016-01810, 2183502-2016-01811, 2183502-2016-01812, 2183502-2016-01813, 2183502-2016-01814, and 2183502-2016-01816.
|